Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical significance of the lymph node ratio in N1 breast cancer

  • Kim, Jaeho (Department of Radiation Oncology, Keimyung University School of Medicine) ;
  • Kim, Jin Hee (Department of Radiation Oncology, Keimyung University School of Medicine) ;
  • Kim, Ok Bae (Department of Radiation Oncology, Keimyung University School of Medicine) ;
  • Oh, Young Kee (Department of Radiation Oncology, Keimyung University School of Medicine) ;
  • Park, Seung Gyu (Department of Radiation Oncology, Dogae Health Subcenter)
  • Received : 2017.01.04
  • Accepted : 2017.03.27
  • Published : 2017.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The purpose of this study was to evaluate the prognostic value of the lymph node ratio (LNR), which was defined as the proportion of involved nodes of all dissected nodes, in pN1 breast cancer. Materials and Methods: We retrospectively analyzed the clinical data of patients with pN1 breast cancer (n = 144) treated at Keimyung University Dongsan Medical Center, Daegu, Korea between 2001 and 2010. The median age was 46 years (range, 27 to 66 years). The LNR was 0.01-0.15 (low LNR) in 130 patients and >0.15 (high LNR) in 14 patients. Sixty-five patients (45.1%) had T1 tumors, 74 (51.4%) had T2 tumors, and 5 (3.5%) had T3 tumors. Eighty-eight patients (61.1%) underwent total mastectomy and 56 (38.9%) underwent partial mastectomy. Fifty-nine patients (41.0%) underwent radiotherapy and 12 (8.3%) underwent regional radiotherapy. The median follow-up period was 65 months. Results: The 5- and 10-year disease-free survival (DFS) rates were 92.7% and 82.4%, respectively. Univariate analyses revealed that high LNR (p = 0.004), total mastectomy (p = 0.006), no local radiotherapy (p = 0.036), and stage T2 or T3 (p = 0.010) were associated with worse DFS. In multivariable analysis, only high LNR (p = 0.015) was associated with worse DFS. Conclusion: High LNR is an independent prognostic factor in pN1 breast cancer and could be an indication for adjuvant radiotherapy in these patients.

Keywords

References

  1. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-106. https://doi.org/10.1016/S0140-6736(05)67887-7
  2. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949-55. https://doi.org/10.1056/NEJM199710023371401
  3. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: breast cancer (version 2.2016) [Internet]. Fort Washington, PA: National Comprehensive Cancer Network; c2017 [cited 2017 Jun 1]. Available from: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
  4. Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 2007;82:247-53. https://doi.org/10.1016/j.radonc.2007.02.001
  5. Han TJ, Kang EY, Jeon W, et al. The prognostic value of the nodal ratio in N1 breast cancer. Radiat Oncol 2011;6:131. https://doi.org/10.1186/1748-717X-6-131
  6. Recht A, Bartelink H, Fourquet A, et al. Postmastectomy radiotherapy: questions for the twenty-first century. J Clin Oncol 1998;16:2886-9. https://doi.org/10.1200/JCO.1998.16.8.2886
  7. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1539-69. https://doi.org/10.1200/JCO.2001.19.5.1539
  8. Truong PT, Olivotto IA, Whelan TJ, Levine M; Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional postmastectomy radiotherapy. CMAJ 2004;170:1263-73. https://doi.org/10.1503/cmaj.1031000
  9. Megale Costa LJ, Soares HP, Gaspar HA, et al. Ratio between positive lymph nodes and total dissected axillaries lymph nodes as an independent prognostic factor for diseasefree survival in patients with breast cancer. Am J Clin Oncol 2004;27:304-6. https://doi.org/10.1097/01.COC.0000071941.70772.DC
  10. Vinh-Hung V, Verkooijen HM, Fioretta G, et al. Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol 2009;27:1062-8. https://doi.org/10.1200/JCO.2008.18.6965
  11. Woodward WA, Vinh-Hung V, Ueno NT, et al. Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol 2006;24:2910-6. https://doi.org/10.1200/JCO.2005.03.1526
  12. Veronesi U, Zurrida S, Viale G, Galimberti V, Arnone P, Nole F. Rethinking TNM: a breast cancer classification to guide to treatment and facilitate research. Breast J 2009;15:291-5. https://doi.org/10.1111/j.1524-4741.2009.00719.x
  13. Truong PT, Berthelet E, Lee J, Kader HA, Olivotto IA. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 2005;103:2006-14. https://doi.org/10.1002/cncr.20969
  14. Truong PT, Woodward WA, Thames HD, Ragaz J, Olivotto IA, Buchholz TA. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 2007;68:59-65. https://doi.org/10.1016/j.ijrobp.2006.12.017
  15. EBCTCG (Early Breast Cancer Trialists' Collaborative Group). Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 2014;383:2127-35. https://doi.org/10.1016/S0140-6736(14)60488-8
  16. Whelan TJ, Olivotto IA, Levine MN. Regional nodal irradiation in early-stage breast cancer. N Engl J Med 2015;373:1878-9.

Cited by

  1. Chest wall recurrence in pT1-2N0-1 breast cancer patients after mastectomy without radiotherapy vol.169, pp.3, 2017, https://doi.org/10.1007/s10549-018-4707-0
  2. Malignant and borderline phyllodes tumors of the breast: a multicenter study of 362 patients (KROG 16-08) vol.171, pp.2, 2018, https://doi.org/10.1007/s10549-018-4838-3
  3. Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group study vol.29, pp.4, 2017, https://doi.org/10.3802/jgo.2018.29.e48
  4. Effects of trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-overexpressing breast cancer patients treated with chemotherapy and radiotherapy vol.172, pp.3, 2017, https://doi.org/10.1007/s10549-018-4966-9
  5. Grade-lymph node ratio predicts the survival of breast cancer in different molecular types : A surveillance, epidemiology, and end results population-based analysis vol.98, pp.28, 2017, https://doi.org/10.1097/md.0000000000016436
  6. Clinical Significance of Lymph-Node Ratio in Determining Supraclavicular Lymph-Node Radiation Therapy in pN1 Breast Cancer Patients Who Received Breast-Conserving Treatment (KROG 14-18): A Multicenter vol.11, pp.5, 2019, https://doi.org/10.3390/cancers11050680
  7. Comparison of Breast Conserving Surgery Followed by Radiation Therapy with Mastectomy Alone for Pathologic N1 Breast Cancer Patients in the Era of Anthracycline Plus Taxane-Based Chemotherapy: A Multi vol.51, pp.3, 2017, https://doi.org/10.4143/crt.2018.424
  8. Prognostic Value of Lymph Node Ratio in Breast Cancer Patients with Adequate Pathologic Evidence After Neoadjuvant Chemotherapy vol.26, pp.None, 2017, https://doi.org/10.12659/msm.922420
  9. Clinical features and their effect on outcomes of patients with triple negative breast cancer with or without lymph node involvement vol.48, pp.3, 2017, https://doi.org/10.1177/0300060519887259
  10. Regional nodal irradiation in pT1-2N1 breast cancer patients treated with breast-conserving surgery and whole breast irradiation vol.38, pp.1, 2017, https://doi.org/10.3857/roj.2019.00647